Hillhouse-backed Genor seeks to raise $100m at up to $1b valuation

Genor Biopharma Co. is seeking to raise about $100 million from private investors to fuel growth ahead of a potential initial public offering for the Chinese drugmaker, according to people familiar with the matter.